跳至主要内容
临床试验/JPRN-UMIN000011200
JPRN-UMIN000011200已完成未知

Prospective observational study of biologic therapy (Anti-TNF) discontinuation in remitted ulcerative colitis patients and therapeutic optimization - Gari-leo study

Saitama Medical Center, Saitama Medical University0 个研究点目标入组 25 人开始时间: 2013年7月17日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
15years-old 至 75years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Patients who cannot continue administration of anti-TNF alpha antibody such as; Patients with severe infection, patients with active tuberculosis, patients with hypersensitivity to anti-TNF alpha antibody, patients with demyelination diseases, such as multiple sclerosis, patients with congestive heart failure, patients with pregnancy, patients with lactation, patients without informed consent, patients who has malignancy and had been cured form malignancy, patients who experienced colectomy, and patients who has been determined not to be suitable to this study by doctors

研究者

发起方
Saitama Medical Center, Saitama Medical University

相似试验